# CHSY3

## Overview
CHSY3 is a gene that encodes the enzyme chondroitin sulfate synthase 3, which is integral to the biosynthesis of chondroitin sulfate, a vital component of the extracellular matrix and cartilage. This enzyme is categorized as a glycosyltransferase due to its dual activities in transferring glucuronic acid and N-acetylgalactosamine to form the repeating disaccharide units of chondroitin sulfate chains (Yada2003Chondroitina). The protein is localized in the Golgi apparatus, where it plays a crucial role in the elongation of glycosaminoglycan chains, thereby contributing to the structural integrity and function of various tissues (Izumikawa2008Identification). CHSY3 interacts with other members of the chondroitin synthase family to enhance polymerization activity, influencing cell signaling, proliferation, and adhesion (Izumikawa2008Identification). The gene's expression is widespread across human tissues, highlighting its essential role in maintaining cellular and tissue functions (Izumikawa2008Identification).

## Function
CHSY3, also known as chondroitin sulfate synthase 3, is a gene that encodes an enzyme involved in the biosynthesis of chondroitin sulfate, a critical component of the extracellular matrix and cartilage. This enzyme exhibits dual glycosyltransferase activities, specifically glucuronyltransferase and N-acetylgalactosaminyltransferase, which are essential for the synthesis of the repeating disaccharide units in chondroitin sulfate chains (Yada2003Chondroitina). CHSY3 is active in the Golgi apparatus, where it facilitates the elongation of glycosaminoglycan chains, contributing to the structural integrity and function of tissues (Izumikawa2008Identification; Yada2003Chondroitina).

The enzyme plays a significant role in chondroitin polymerization by interacting with other chondroitin synthase family members, such as ChSy-1, ChSy-2, and ChPF, to form enzyme complexes that enhance polymerization activity (Izumikawa2008Identification). These interactions are crucial for the biosynthesis of chondroitin sulfate, influencing cell signaling, proliferation, and adhesion (Izumikawa2008Identification). The expression of CHSY3 is consistent across various human tissues, indicating its widespread role in maintaining cellular and tissue functions (Izumikawa2008Identification).

## Clinical Significance
The CHSY3 gene, encoding chondroitin sulfate synthase 3, is implicated in various clinical conditions, particularly in the context of gastric cancer (GC). Elevated expression of CHSY3 is associated with poor prognosis in GC patients, correlating with advanced tumor stages and reduced overall survival. This upregulation is linked to increased proliferation, migration, and invasion of gastric cancer cells, as well as resistance to chemotherapeutic drugs like cisplatin and docetaxel (Huang2023CHSY3; Wang2024The). CHSY3 expression is also associated with immune infiltration patterns, including higher M2 macrophage infiltration and lower tumor purity, which may contribute to immune evasion and reduced efficacy of immunotherapy (Huang2023CHSY3).

In addition to its role in cancer, CHSY3 is involved in the biosynthesis of glycosaminoglycans, and mutations in this gene can lead to skeletal disorders. Although specific diseases linked to CHSY3 mutations are not detailed in the provided context, alterations in its expression or function could potentially impact cartilage development and joint function (Mizumoto2014Human). The gene's involvement in extracellular matrix organization and signaling pathways further underscores its clinical significance (Wang2024The).


## References


[1. (Izumikawa2008Identification) Tomomi Izumikawa, Toshiyasu Koike, Shoko Shiozawa, Kazuyuki Sugahara, Jun-ichi Tamura, and Hiroshi Kitagawa. Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization. Journal of Biological Chemistry, 283(17):11396–11406, April 2008. URL: http://dx.doi.org/10.1074/jbc.m707549200, doi:10.1074/jbc.m707549200. This article has 122 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m707549200)

[2. (Yada2003Chondroitina) Toshikazu Yada, Takashi Sato, Hiromi Kaseyama, Masanori Gotoh, Hiroko Iwasaki, Norihiro Kikuchi, Yeon-Dae Kwon, Akira Togayachi, Takashi Kudo, Hideto Watanabe, Hisashi Narimatsu, and Koji Kimata. Chondroitin sulfate synthase-3. Journal of Biological Chemistry, 278(41):39711–39725, October 2003. URL: http://dx.doi.org/10.1074/jbc.m304421200, doi:10.1074/jbc.m304421200. This article has 65 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m304421200)

[3. (Wang2024The) Han Wang, Junchang Zhang, Zhuoqi Wei, Songyao Chen, Jiabin Zheng, and Yong Li. The prognostic implications and tumor-promoting functions of chsy3 in gastric cancer. Frontiers in Immunology, May 2024. URL: http://dx.doi.org/10.3389/fimmu.2024.1364979, doi:10.3389/fimmu.2024.1364979. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2024.1364979)

[4. (Mizumoto2014Human) Shuji Mizumoto, Shuhei Yamada, and Kazuyuki Sugahara. Human genetic disorders and knockout mice deficient in glycosaminoglycan. BioMed Research International, 2014:1–24, 2014. URL: http://dx.doi.org/10.1155/2014/495764, doi:10.1155/2014/495764. This article has 42 citations and is from a poor quality or predatory journal.](https://doi.org/10.1155/2014/495764)

[5. (Huang2023CHSY3) Xinkun Huang, Yonghui Liu, Chenyu Qian, Qicheng Shen, Menglong Wu, Bin Zhu, and Ying Feng. Chsy3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration. Journal of Translational Medicine, July 2023. URL: http://dx.doi.org/10.1186/s12967-023-04333-x, doi:10.1186/s12967-023-04333-x. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-023-04333-x)